Seguir
Martin Weltman
Martin Weltman
Associate Professor of Medicine, Sydney Medical School
Dirección de correo verificada de wahs.nsw.gov.au
Título
Citado por
Citado por
Año
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
V Suppiah, M Moldovan, G Ahlenstiel, T Berg, M Weltman, ML Abate, ...
Nature genetics 41 (10), 1100-1104, 2009
23722009
NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome
S Chitturi, S Abeygunasekera, GC Farrell, J Holmes-Walker, JM Hui, ...
Hepatology 35 (2), 373-379, 2002
15382002
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
10562019
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
MD Weltman, GC Farrell, P Hall, M Ingelman-Sundberg, C Liddle
Hepatology 27 (1), 128-133, 1998
7921998
The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study
NA Koloski, M Jones, J Kalantar, M Weltman, J Zaguirre, NJ Talley
Gut 61 (9), 1284-1290, 2012
6812012
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction
MM Richardson, JR Jonsson, EE Powell, EM Brunt, ...
Gastroenterology 133 (1), 80-90, 2007
5112007
Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation
MD Weltman, GC Farrell, C Liddle
Gastroenterology 111 (6), 1645-1653, 1996
5041996
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial
J Grebely, O Dalgard, B Conway, EB Cunningham, P Bruggmann, ...
The lancet Gastroenterology & hepatology 3 (3), 153-161, 2018
3022018
HFE mutations, hepatic iron, and fibrosis: ethnic‐specific association of NASH with C282Y but not with fibrotic severity
S Chitturi, M Weltman, GC Farrell, D McDonald, C Liddle, ...
Hepatology 36 (1), 142-149, 2002
2912002
Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
J Behary, N Amorim, XT Jiang, A Raposo, L Gong, E McGovern, R Ibrahim, ...
Nature Communications 12 (1), 187, 2021
2342021
Which patients with hepatitis C develop liver complications?
MH Khan, GC Farrell, K Byth, R Lin, M Weltman, J George, ...
Hepatology 31 (2), 513-520, 2000
2312000
Coinfection with hepatitis B and C or B, C and δ viruses results in severe chronic liver disease and responds poorly to terferon‐a treatment
MD Weltman, A Brotodihardjo, EB Crewe, GC Farrell, M Bililus, ...
Journal of viral hepatitis 2 (1), 39-45, 1995
2211995
Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi‐centre, randomized, double‐blind, placebo‐controlled trial
KC Morley, M Teesson, SC Reid, C Sannibale, C Thomson, N Phung, ...
Addiction 101 (10), 1451-1462, 2006
2012006
Influence of aging on oral-pharyngeal bolus transit and clearance during swallowing: scintigraphic study
IJ Cook, MD Weltman, K Wallace, DW Shaw, E McKay, RC Smart, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 266 (6 …, 1994
1891994
Duodenal eosinophilia and early satiety in functional dyspepsia: confirmation of a positive association in an A ustralian cohort
MM Walker, KR Aggarwal, LSE Shim, M Bassan, JS Kalantar, ...
Journal of gastroenterology and hepatology 29 (3), 474-479, 2014
1872014
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
M Eslam, AM Hashem, R Leung, M Romero-Gomez, T Berg, GJ Dore, ...
Nature communications 6 (1), 6422, 2015
1772015
Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance
KL Milner, D van der Poorten, M Trenell, AB Jenkins, A Xu, G Smythe, ...
Gastroenterology 138 (3), 932-941. e3, 2010
1732010
Modelling the hepatitis C virus epidemic in Australia
K Razali, HH Thein, J Bell, M Cooper-Stanbury, K Dolan, G Dore, ...
Drug and alcohol dependence 91 (2-3), 228-235, 2007
1712007
Global multi-stakeholder endorsement of the MAFLD definition
N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ...
The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022
1662022
An association between non‐alcoholic fatty liver disease and polycystic ovarian syndrome
MM Brzozowska, G Ostapowicz, MD Weltman
Journal of gastroenterology and hepatology 24 (2), 243-247, 2009
1482009
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20